← Back to charts
IOLEvidence (Qvision Academy) icon
APP STORE

IOLEvidence (Qvision Academy)

Qvision, Departamento de Oftalmología · Education · United States store
NOT IN TOP 100 HERE
View on App Store ↗ Instagram card
Revenue a month, worldwide EST
$361
Likely $120 to $1.1K
▲ 120.6% in 15 days
New ratings
+0
in 1 days, 60 in total
Rating
4.7 of 5
7 ratings in this store
Countries it ranks in
0
was 0 on Oct 19, 2026

Revenue

Estimated from the grossing charts of Oct 26, 2026 in the 53 countries we track, and ratings growth on the App Store.

EST. REVENUE / YEAR · WORLDWIDE
$4.3K
1.3 new ratings a month on average since launch
EST. LIFETIME DOWNLOADS
245 to 700
Estimated from ratings count
WHERE ITS USERS ARE · SHARE OF RATINGS
  • Spain 14 ratings23%
  • Brazil 12 ratings20%
  • Mexico 9 ratings15%
  • United States 7 ratings12%
  • Philippines 6 ratings10%
  • Germany 4 ratings7%
  • Turkey 3 ratings5%
  • Australia 2 ratings3%
HOW SURE ARE WE
Not in any grossing chart, so this comes from ratings growth (1.3 new ratings a month on average since launch): revenue grows with new ratings, more slowly for apps that collect ratings fast. Tested on 418 apps with verified revenue: typically off by about 2 times, and big earners tend to come out low. Countries we don't track (and Google Play in China, which doesn't exist) aren't included, and neither are ads or web payments. Gross revenue before store fees.
RATINGS
7
AVG RATING
4.71
PRICE
Free
AGE
3.7y
LAST UPDATE
3d ago
VERSION
26.4.1
SIZE
64 MB
AGE RATING
4+

Last 30 days

From our daily snapshots of every grossing chart and daily ratings counts.

DAYS IN A GROSSING CHART
3 / 30
COUNTRIES NOW
0 (was 0)
NEW RATINGS, LAST 1 DAYS
+0
EST. REVENUE A MONTH, DAILY · APP STORE EST
Show daily values
Sep 27, 2026not in a grossing chart
Sep 28, 2026not in a grossing chart
Sep 29, 2026not in a grossing chart
Sep 30, 2026not in a grossing chart
Oct 1, 2026not in a grossing chart
Oct 2, 2026not in a grossing chart
Oct 3, 2026not in a grossing chart
Oct 4, 2026not in a grossing chart
Oct 5, 2026not in a grossing chart
Oct 6, 2026not in a grossing chart
Oct 7, 2026not in a grossing chart
Oct 8, 2026not in a grossing chart
Oct 9, 2026not in a grossing chart
Oct 10, 2026$870 a month
Oct 11, 2026not in a grossing chart
Oct 12, 2026not in a grossing chart
Oct 13, 2026not in a grossing chart
Oct 14, 2026not in a grossing chart
Oct 15, 2026not in a grossing chart
Oct 16, 2026not in a grossing chart
Oct 17, 2026$1.7K a month
Oct 18, 2026not in a grossing chart
Oct 19, 2026not in a grossing chart
Oct 20, 2026not in a grossing chart
Oct 21, 2026not in a grossing chart
Oct 22, 2026not in a grossing chart
Oct 23, 2026not in a grossing chart
Oct 24, 2026not in a grossing chart
Oct 25, 2026$1.9K a month
Oct 26, 2026not in a grossing chart
The same estimate as the headline, saved every day. Best rank Sep 27, 2026: not ranked. Now: not ranked.
RATINGS IN THE CORE COUNTRIES, DAILY
Show daily values
Oct 25, 202660 ratings
Oct 26, 202660 ratings
60 on Oct 25, 2026, 60 on Oct 26, 2026. New ratings track new downloads, even outside the charts.

Money and momentum

Measured from the store, not estimated.

WHAT IT CHARGES
1 purchase listed
  • Pro$39.99
Top in-app purchases as listed on the App Store, in local prices.
REVIEW MOMENTUM
Too few reviews
Fewer than 3 recent written reviews in this country.
RELEASE CADENCE
2 updates in 90 days
  • Typical gap between releases35 days
From the last 25 versions listed on the App Store.
RATING BREAKDOWN
7 ratings
5★86%
4★0%
3★14%
2★0%
1★0%

Apps like this

Same category, earning about as much.

Store screenshots

ScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshotScreenshot

App Store ads

Apple Search Ads this app ran in the last 90 days, from Apple's public ad repository.

No App Store ads in the EU
None in the last 90 days.

Apple only publishes ads shown in the EU (EU Digital Services Act), with a 7 day delay. An app that advertises only outside the EU shows nothing here.

Growth research

Where this app is buying and earning its users. Each link opens pre filtered.

ASO keywords

Most repeated terms in the listing. Highlighted ones also appear in the title.

iolevidence5evidence5reports5evidence based3optimization reports3iol3outcomes3quality3optimization3pro3based2insights2refractive2clinical2synthesized2studies2plus2confidence2comparisons2key2confirmatory2access2variability2between2

What's new in 26.4.1

20 new reports

Released Feb 5, 2023. Current version shipped Oct 23, 2026.

Store description

IOLEvidence: Evidence-based IOL selection at your fingertips Instant insights for cataract and refractive lens surgeons — answer clinical questions in seconds with synthesized outcomes from peer-reviewed IOL studies, plus quality assessment to gauge confidence. ABOUT US & OUR APPROACH - IOLEvidence is built by the Research & Evidence Department of Qvision, led by Dr. Joaquín Fernández. - For years, our team has done what every busy clinician wishes they had time for: finding the right studies, appraising quality, extracting relevant endpoints, and translating results into practical comparisons. - IOLEvidence puts that work in the palm of your hand—so you can make evidence-based decisions faster while saving countless hours of reading and interpretation. KEY FEATURES - Confirmatory + Optimization reports — access both types from Search, clearly labeled. - Standardized clinical outcomes & confounders — filter harmonized outcomes and explore confounding factors like age, baseline vision, and refractive characteristics. - Easy summaries from difficult papers — consistent structure (key message, applicability, population, requirements, and more). - Quality Score — judge confidence at a glance before applying findings to practice. - Targeted comparisons — bookmark/select reports for precise comparison across IOL models. - Understand variability — interpret differences between IOLs, procedures, and patient populations. - Meta-analysis insights (when possible) — see between-study variability and whether additional evidence may be needed. - Expert community — suggest new articles, add expert comments, and help improve the knowledge base. GET STARTED FOR FREE - Download IOLEvidence and access the 20 most recent synthesized and evaluated reports at no cost and to the new added Optimization Reports. UPGRADE TO PRO TO UNLOCK - All Optimization and Confirmatory reports (800+), plus periodic updates with new evidence. - Rapid Learning lessons. PRO SUBSCRIPTION INFORMATION - IOLEvidence is freemium. PRO costs 49,99 € per year (may vary by country). Payment is charged to your iTunes account upon confirmation of purchase. Subscription automatically renews unless auto-renewal is turned off at least 24 hours before the end of the current period. Renewal occurs within 24 hours prior to the end of the current period. Manage or cancel in your Account Settings. Any unused portion of a free trial period, if offered, is forfeited when the user purchases a subscription, where applicable. OUR COMMITMENT - All proceeds generated through the application are allocated to fund assistance projects of the Elena Barraquer Foundation for the eradication of preventable blindness caused by cataracts.

See this store page in another country

Prices, ranks and reviews are per country. Revenue above is already worldwide.

More from Qvision, Departamento de Oftalmología

CalibratorVS
Photo & Video
0 ratingsAnalyze →
Multifocal Lens Analyzer
Education
1 ratingsAnalyze →
AmblyopiaVA
Medical
0 ratingsAnalyze →
BigSIA
Education
0 ratingsAnalyze →
VisionC (ETDRS Visual Acuity)
Medical
0 ratingsAnalyze →